Littleton, MA, United States of America

Charles D Meyers

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Anji Pharmaceuticals Inc.. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Charles D. Meyers

Introduction

Charles D. Meyers is an accomplished inventor based in Littleton, MA (US). He has made significant contributions to the field of medical treatments, particularly in the area of pancreatitis. His innovative approach has led to the development of a unique patent that addresses this serious condition.

Latest Patents

Charles D. Meyers holds a patent for "Compositions and methods for treating pancreatitis." This patent outlines methods related to inhibiting or treating pancreatitis in a subject in need thereof, which include the use of a proprotein convertase subtilisin kexin 9 (PCSK9) inhibitor. The disclosed PCSK9 inhibitors and compositions can be utilized for the treatment, inhibition, or prevention of pancreatitis. Treatment methods can involve administering a therapeutically effective amount of a PCSK9 inhibitor to the subject.

Career Highlights

Meyers is currently associated with Anji Pharmaceuticals Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key figure in the advancement of medical treatments.

Collaborations

Some of his notable coworkers include Brian K. Hubbard and Michael H. Serrano-Wu. Their collaborative efforts contribute to the ongoing research and development initiatives at Anji Pharmaceuticals Inc.

Conclusion

Charles D. Meyers exemplifies the spirit of innovation in the medical field through his groundbreaking work on treatments for pancreatitis. His contributions are paving the way for new therapeutic options that can significantly improve patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…